Get started
EXPRES2ION BIOTECH HOLDING ABEXPRES2ION BIOTECH HOLDING ABEXPRES2ION BIOTECH HOLDING AB

EXPRES2ION BIOTECH HOLDING AB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

EXPRS2 chart


Full chart

Key stats


Market capitalization
‪55.29 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−20.8 SEK
Net income (FY)
‪−91.40 M‬ SEK
Revenue (FY)
‪7.05 M‬ SEK
Shares float
‪2.10 M‬
Beta (1Y)
0.56

Employees


Employees (FY)
21
Change (1Y)
−6 −22.22%
Revenue / Employee (1Y)
‪335.71 K‬ SEK
Net income / Employee (1Y)
‪−4.35 M‬ SEK

About EXPRES2ION BIOTECH HOLDING AB


Sector
Health Technology
Industry
Biotechnology
CEO
Bent U. Frandsen
Website
expres2ionbio.com
Headquarters
Hørsholm
Founded
2010
ISIN
SE0023261292
FIGI
BBG00D3JNGY8
Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. Its products and services include custom made proteins and reagents; transfection reagent; process development; feasibility studies; and licensing. The company was founded by Charlotte Dyring, Wian de Jongh, and Martin Roland Jensen in 2010 and is headquartered in Hørsholm, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EXPRS2 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EXPRS2 is 20.2 SEK — it has decreased by −5.45% in the past 24 hours. Watch EXPRES2ION BIOTECH HOLDING AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange EXPRES2ION BIOTECH HOLDING AB stocks are traded under the ticker EXPRS2.
EXPRS2 stock has fallen by −6.31% compared to the previous week, the month change is a 10.99% rise, over the last year EXPRES2ION BIOTECH HOLDING AB has showed a −77.15% decrease.
We've gathered analysts' opinions on EXPRES2ION BIOTECH HOLDING AB future price: according to them, EXPRS2 price has a max estimate of 303.00 SEK and a min estimate of 303.00 SEK. Watch EXPRS2 chart and read a more detailed EXPRES2ION BIOTECH HOLDING AB stock forecast: see what analysts think of EXPRES2ION BIOTECH HOLDING AB and suggest that you do with its stocks.
EXPRS2 reached its all-time high on Aug 9, 2021 with the price of 2,691.0 SEK, and its all-time low was 17.8 SEK and was reached on Nov 22, 2024. View more price dynamics on EXPRS2 chart.
See other stocks reaching their highest and lowest prices.
EXPRS2 stock is 9.00% volatile and has beta coefficient of 0.56. Track EXPRES2ION BIOTECH HOLDING AB stock price on the chart and check out the list of the most volatile stocks — is EXPRES2ION BIOTECH HOLDING AB there?
Today EXPRES2ION BIOTECH HOLDING AB has the market capitalization of ‪43.69 M‬, it has increased by 1.85% over the last week.
Yes, you can track EXPRES2ION BIOTECH HOLDING AB financials in yearly and quarterly reports right on TradingView.
EXPRS2 net income for the last quarter is ‪−10.46 M‬ SEK, while the quarter before that showed ‪2.54 M‬ SEK of net income which accounts for −512.30% change. Track more EXPRES2ION BIOTECH HOLDING AB financial stats to get the full picture.
No, EXPRS2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 21.00 employees. See our rating of the largest employees — is EXPRES2ION BIOTECH HOLDING AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXPRES2ION BIOTECH HOLDING AB EBITDA is ‪−71.35 M‬ SEK, and current EBITDA margin is ‪−1.51 K‬%. See more stats in EXPRES2ION BIOTECH HOLDING AB financial statements.
Like other stocks, EXPRS2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXPRES2ION BIOTECH HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXPRES2ION BIOTECH HOLDING AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXPRES2ION BIOTECH HOLDING AB stock shows the sell signal. See more of EXPRES2ION BIOTECH HOLDING AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.